HomeCompareERVFF vs PFE

ERVFF vs PFE: Dividend Comparison 2026

ERVFF yields 7692.31% · PFE yields 6.20%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ERVFF wins by $4177739098279589.00M in total portfolio value
10 years
ERVFF
ERVFF
● Live price
7692.31%
Share price
$0.03
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4177739098279589.00M
Annual income
$4,073,565,928,588,968,500,000.00
Full ERVFF calculator →
PFE
Pfizer Inc.
● Live price
6.20%
Share price
$27.76
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$51.1K
Annual income
$27,210.54
Full PFE calculator →

Portfolio growth — ERVFF vs PFE

📍 ERVFF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodERVFFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ERVFF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ERVFF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ERVFF
Annual income on $10K today (after 15% tax)
$653,846.15/yr
After 10yr DRIP, annual income (after tax)
$3,462,531,039,300,623,000,000.00/yr
PFE
Annual income on $10K today (after 15% tax)
$526.66/yr
After 10yr DRIP, annual income (after tax)
$23,128.96/yr
At 15% tax rate, ERVFF beats the other by $3,462,531,039,300,623,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ERVFF + PFE for your $10,000?

ERVFF: 50%PFE: 50%
100% PFE50/50100% ERVFF
Portfolio after 10yr
$2088869549139794.50M
Annual income
$2,036,782,964,294,484,200,000.00/yr
Blended yield
97.51%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

ERVFF
No analyst data
Altman Z
5.3
Piotroski
1/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-0.9% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ERVFF buys
0
PFE buys
0
No recent congressional trades found for ERVFF or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricERVFFPFE
Forward yield7692.31%6.20%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$4177739098279589.00M$51.1K
Annual income after 10y$4,073,565,928,588,968,500,000.00$27,210.54
Total dividends collected$4170772265337663.00M$60.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ERVFF vs PFE ($10,000, DRIP)

YearERVFF PortfolioERVFF Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$779,931$769,230.77$9,161$701.38+$770.8KERVFF
2$56,904,315$56,069,789.30$8,610$859.79+$56.90MERVFF
3$3,884,151,673$3,823,264,055.84$8,366$1,081.25+$3884.14MERVFF
4$248,050,254,929$243,894,212,638.74$8,483$1,405.66+$248050.25MERVFF
5$14,822,056,221,428$14,556,642,448,653.80$9,084$1,907.24+$14822056.21MERVFF
6$828,776,618,419,079$812,917,018,262,150.50$10,418$2,732.78+$828776618.41MERVFF
7$43,367,472,132,823,630$42,480,681,151,115,220.00$13,007$4,193.56+$43367472132.81MERVFF
8$2,123,871,047,251,591,000$2,077,467,852,069,469,400.00$18,010$7,005.87+$2123871047251.57MERVFF
9$97,358,102,514,598,310,000$95,085,560,494,039,100,000.00$28,216$12,979.89+$97358102514598.28MERVFF
10$4,177,739,098,279,589,000,000$4,073,565,928,588,968,500,000.00$51,081$27,210.54+$4177739098279589.00MERVFF

ERVFF vs PFE: Complete Analysis 2026

ERVFFStock

Erin Ventures Inc. is an emerging international junior mining and exploration company engaged in the acquisition, exploration, and development of precious metal properties. Erin Venture's strategy is to uncover and capitalize on unique development opportunities within different regions internationally. The Company's objective is to increase its mineral reserves by developing current properties and through the acquisition of additional mining projects. We are expanding exploration activities at both our Ceibo Chico gold property in Belize, and our Deep River gold project in North Carolina and expect to offset costs on both properties through recently established gold production.

Full ERVFF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this ERVFF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ERVFF vs SCHDERVFF vs JEPIERVFF vs OERVFF vs KOERVFF vs MAINERVFF vs JNJERVFF vs MRKERVFF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.